People who use these products are therefore at a very high risk of treatment failure, unexpected and serious health problems and dangerous interactions with other medicines
"It's not the GLP-1 that lost the weight," he told The Post
Benefits Semaglutide and liraglutide share a few common benefits, such as: Both drugs promote blood sugar control in patients with type 2 diabetes Semaglutide (Wegovy) and liraglutide (Saxenda) help reduce body weight in obese and overweight patients Both drugs have potential cardiovascular benefits and reduce the risk of heart attack, stroke, and cardiovascular death Side effects As semaglutide and liraglutide belong to the same class of drugs (GLP-1 receptor agonist), they have common side effects such as nausea, vomiting, diarrhea, constipation, stomach pain, injection site reaction, and pancreatitis
Safe progression: It is designed specifically as an effective next step for those who already tolerate the 2.4mg injection with minimal to no side effects
Insurance Coverage: Most commercial insurance plans that cover weight loss medications treat both forms similarly, with copays as low as $25 for eligible patients